Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity

Molecular Cell

Volumn 49, Issue 2, 2013, Pages 331-338

  Py, Bénédicte F ^a   Kim, Mi Sung ^a   Vakifahmetoglu Norberg, Helin ^a   Yuan, Junying ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCC3 PROTEIN; CRYOPYRIN; INFLAMMASOME; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEUBIQUITINATION; MACROPHAGE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; UBIQUITINATION;

ANIMALS; CARRIER PROTEINS; CASPASE 1; ENDOPEPTIDASES; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; PEPTIDE MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PYRANS; RNA, SMALL INTERFERING; SULFHYDRYL COMPOUNDS; TOLL-LIKE RECEPTOR 4; UBIQUITINATION;

BACTERIA (MICROORGANISMS);

EID: 84872782298     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2012.11.009     Document Type: Article

References (18)

1. Aleo E., Henderson C.J., Fontanini A., Solazzo B., Brancolini C. Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis. Cancer Res. 2006, 66:9235-9244.
2. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
3. Boudreau H.E., Broustas C.G., Gokhale P.C., Kumar D., Mewani R.R., Rone J.D., Haddad B.R., Kasid U. Expression of BRCC3, a novel cell cycle regulated molecule, is associated with increased phospho-ERK and cell proliferation. Int. J. Mol. Med. 2007, 19:29-39.
4. Cilenti L., Balakrishnan M.P., Wang X.L., Ambivero C., Sterlicchi M., del Monte F., Ma X.L., Zervos A.S. Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination. J. Mol. Cell. Cardiol. 2011, 50:652-661.
5. Cooper E.M., Cutcliffe C., Kristiansen T.Z., Pandey A., Pickart C.M., Cohen R.E. K63-specific deubiquitination by two JAMM/MPN+ complexes: BRISC-associated Brcc36 and proteasomal Poh1. EMBO J. 2009, 28:621-631.
6. Fernandes-Alnemri T., Yu J.W., Datta P., Wu J., Alnemri E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458:509-513.
7. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., Fitzgerald K.A., Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008, 9:847-856.
8. Iyer S.S., Pulskens W.P., Sadler J.J., Butter L.M., Teske G.J., Ulland T.K., Eisenbarth S.C., Florquin S., Flavell R.A., Leemans J.C., Sutterwala F.S. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. USA 2009, 106:20388-20393.
9. Juliana C., Fernandes-Alnemri T., Wu J., Datta P., Solorzano L., Yu J.W., Meng R., Quong A.A., Latz E., Scott C.P., Alnemri E.S. Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J. Biol. Chem. 2010, 285:9792-9802.
10. Keller M., Rüegg A., Werner S., Beer H.D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008, 132:818-831.
11. López-Castejón G., Pelegrín P. Current status of inflammasome blockers as anti-inflammatory drugs. Expert Opin. Investig. Drugs 2012, 21:995-1007.
12. Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., Roose-Girma M., Erickson S., Dixit V.M. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430:213-218.
13. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27:229-265.
14. Newton K., Matsumoto M.L., Wertz I.E., Kirkpatrick D.S., Lill J.R., Tan J., Dugger D., Gordon N., Sidhu S.S., Fellouse F.A., et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008, 134:668-678.
15. Shao G., Lilli D.R., Patterson-Fortin J., Coleman K.A., Morrissey D.E., Greenberg R.A. The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks. Proc. Natl. Acad. Sci. USA 2009, 106:3166-3171.
16. Shinkai K., McCalmont T.H., Leslie K.S. Cryopyrin-associated periodic syndromes and autoinflammation. Clin. Exp. Dermatol. 2008, 33:1-9.
17. Sowa M.E., Bennett E.J., Gygi S.P., Harper J.W. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009, 138:389-403.
18. Stehlik C., Dorfleutner A. COPs and POPs: modulators of inflammasome activity. J. Immunol. 2007, 179:7993-7998.